Construction of a lentiviral vector for RNA interference of human EGFL7 gene and its stable expression in human laryngeal carcinoma cells

Ge-hua ZHANG,Li-hong CHANG,Jin YE,Shi-min ZHUANG,Kai WANG,Jing-jia LI
DOI: https://doi.org/10.3969/j.issn.1000-4718.2013.10.025
2013-01-01
Abstract:AIM: To investigate the role of epidermal growth factor-like domain 7( EGFL7) in the pathogenesis and progress of laryngeal carcinoma via constructing a lentiviral expression vector for RNA interference( RNAi) of human EGFL7 gene and assessing the gene-silencing effect of the vector in human laryngeal epidermoid carcinoma( HEp-2)cells. METHODS: Specific RNAi target sequences were designed focused on human EGFL7 gene sequence. The doublestranded oligonucleotides were cloned into the pcDNA6. 2-GW / EmGFP-miR plasmid after synthesis and annealing. A positive clone was subcloned into the pLenti6. 3-MCS / V5-DEST vector after sequence analysis. The recombinant lentivirus was harvested from 293T cells co-transfected with the positive recombinant plasmid and lentiviral packing materials. HEp-2cells were infected with the recombinant lentivirus and the cells with stable EGFL7 knockdown were screened by blasticidin selection. EGFL7 mRNA expression in the cells was determined by real-time fluorescence quantitative PCR. RESULTS:A recombinant lentiviral vector expressing short hairpin RNAs( shRNAs) against EGFL7 gene was obtained and confirmed by DNA sequencing. The virus titer was 5 × 1011TU / L,and the silencing efficiency was 97%. CONCLUSION: A lentiviral vector targeting human EGFL7 gene,capable of stable EGFL7 gene knockdown in HEp-2 cells,has been successfully constructed,which provides a basis for further study of the relationship between human laryngeal carcinoma and EGFL7protein.
What problem does this paper attempt to address?